Your session is about to expire
← Back to Search
The radon app for Lung Cancer
N/A
Waitlist Available
Led By Gary G Schwartz
Research Sponsored by University of North Dakota
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
The principal eligibility criterion is that participants own a smartphone.
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through the study completion - 3 months
Awards & highlights
Study Summary
The purpose of this research study is to compare the effectiveness of radon information delivered via the radon app vs. a traditional approach (printed brochure). The prevalence of exceptionally high levels of residential radon in ND, coupled with public's poor understanding of this hazard, is a critical public health problem.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ through the study completion - 3 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through the study completion - 3 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change from baseline radon knowledge at 3 months
Radon
Using the radon test kit
Trial Design
2Treatment groups
Experimental Treatment
Placebo Group
Group I: The radon appExperimental Treatment1 Intervention
Participants assigned to the radon app group will be asked to use the radon app for three months where they will be exposed to mobile friendly educational content that is repurposed from educational print brochures about radon published by EPA.
Group II: Print brochuresPlacebo Group1 Intervention
Participants assigned to the print brochure group will receive three educational print brochures about radon published by EPA via postal mails for three months (one per each month).
Find a Location
Who is running the clinical trial?
University of North DakotaLead Sponsor
15 Previous Clinical Trials
1,097 Total Patients Enrolled
Soojung KimStudy DirectorUniversity of North Dakota
1 Previous Clinical Trials
299 Total Patients Enrolled
Gary G SchwartzPrincipal InvestigatorUniversity of North Dakota
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger